Valeant Pharmaceuticals reported $2.11B in Sales Revenues for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Amgen AMGN:US $ 6706M 180M
Ani Pharmaceuticals ANIP:US $ 52.06M 3.44M
Aphria Inc APH:CN C$ 153.64M 6.89M
Aurora Cannabis Inc ACB:CN 60.11M 5.5M
Biogen BIIB:US $ 2778.9M 3.9M
Bristol Myers Squibb BMY:US $ 11624M 79M
Canopy Growth Corp WEED:CN C$ 131.37M 4.84M
Catalent CTLT:US $ 1025M 163.2M
Corcept Therapeutics CORT:US $ 96.13M 4.54M
Danaher DHR:US $ 7229M 11M
Drreddys Laboratories RDY:US $ 57632M 8438M
Eli Lilly And LLY:US $ 6772.8M 32.7M
Endo International Ordinary Shares ENDP:US $ 772.03M 58.2M
Gilead Sciences GILD:US $ 7421M 1204M
Gw Pharmaceuticals GWPH:US $ 152.47M 4.24M
Horizon Pharma HZNP:US $ 1036.99M 204.44M
JAZZ PHA JAZZ:US $ 838.12M 86.3M
Lannett LCI:US $ 101.52M 4.48M
Nektar Therapeutics NKTR:US $ 24.92M 3.41M
Pacira Pharmaceuticals PCRX:US $ 127.72M 7.87M
Perrigo Ordinary Shares PRGO:US $ 1042.7M 61.6M
Phibro Animal Health PAHC:US $ 214.66M 5.61M
Prestige Brands PBH:US $ 276.23M 7.04M
Revance Therapeutics RVNC:US $ 19.74M 0.94M
Supernus Pharmaceuticals SUPN:US $ 148.46M 7.14M
Valeant Pharmaceuticals VRX:CN $ 2111M 11M
Vertex Pharmaceuticals VRTX:US $ 1984.16M 190.79M
Zoetis ZTS:US $ 1990M 42M